GO:0006479 | protein methylation | 30.22% (42/139) | 4.86 | 0.0 | 0.0 |
GO:0051567 | histone H3-K9 methylation | 29.5% (41/139) | 5.51 | 0.0 | 0.0 |
GO:0034968 | histone lysine methylation | 30.22% (42/139) | 5.18 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 30.22% (42/139) | 5.01 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 39.57% (55/139) | 4.33 | 0.0 | 0.0 |
GO:0018022 | peptidyl-lysine methylation | 30.22% (42/139) | 5.17 | 0.0 | 0.0 |
GO:0016571 | histone methylation | 30.22% (42/139) | 4.87 | 0.0 | 0.0 |
GO:0016570 | histone modification | 33.81% (47/139) | 4.74 | 0.0 | 0.0 |
GO:0000911 | cytokinesis by cell plate formation | 33.09% (46/139) | 5.61 | 0.0 | 0.0 |
GO:0000910 | cytokinesis | 33.09% (46/139) | 5.58 | 0.0 | 0.0 |
GO:0008283 | cell population proliferation | 31.65% (44/139) | 5.76 | 0.0 | 0.0 |
GO:0006275 | regulation of DNA replication | 25.9% (36/139) | 5.74 | 0.0 | 0.0 |
GO:0008213 | protein alkylation | 30.22% (42/139) | 4.86 | 0.0 | 0.0 |
GO:0000226 | microtubule cytoskeleton organization | 28.78% (40/139) | 5.05 | 0.0 | 0.0 |
GO:0061647 | histone H3-K9 modification | 29.5% (41/139) | 5.51 | 0.0 | 0.0 |
GO:0006306 | DNA methylation | 25.18% (35/139) | 5.35 | 0.0 | 0.0 |
GO:0006305 | DNA alkylation | 25.18% (35/139) | 5.35 | 0.0 | 0.0 |
GO:0044728 | DNA methylation or demethylation | 25.18% (35/139) | 5.33 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 30.22% (42/139) | 4.62 | 0.0 | 0.0 |
GO:0006304 | DNA modification | 25.18% (35/139) | 5.32 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 27.34% (38/139) | 4.86 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 28.06% (39/139) | 4.74 | 0.0 | 0.0 |
GO:0007010 | cytoskeleton organization | 29.5% (41/139) | 4.48 | 0.0 | 0.0 |
GO:0018193 | peptidyl-amino acid modification | 30.22% (42/139) | 4.38 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 31.65% (44/139) | 4.12 | 0.0 | 0.0 |
GO:0032259 | methylation | 31.65% (44/139) | 4.12 | 0.0 | 0.0 |
GO:1901987 | regulation of cell cycle phase transition | 17.99% (25/139) | 6.09 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 17.27% (24/139) | 6.2 | 0.0 | 0.0 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 17.27% (24/139) | 6.09 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 30.22% (42/139) | 3.91 | 0.0 | 0.0 |
GO:0007346 | regulation of mitotic cell cycle | 17.99% (25/139) | 5.61 | 0.0 | 0.0 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 15.83% (22/139) | 6.1 | 0.0 | 0.0 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 15.83% (22/139) | 6.1 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 19.42% (27/139) | 5.23 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 38.13% (53/139) | 3.04 | 0.0 | 0.0 |
GO:0048449 | floral organ formation | 16.55% (23/139) | 5.03 | 0.0 | 0.0 |
GO:0006464 | cellular protein modification process | 35.25% (49/139) | 2.7 | 0.0 | 0.0 |
GO:0036211 | protein modification process | 35.25% (49/139) | 2.7 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 42.45% (59/139) | 2.29 | 0.0 | 0.0 |
GO:1905393 | plant organ formation | 17.27% (24/139) | 4.62 | 0.0 | 0.0 |
GO:0016458 | obsolete gene silencing | 12.23% (17/139) | 5.87 | 0.0 | 0.0 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 19.42% (27/139) | 4.14 | 0.0 | 0.0 |
GO:0009909 | regulation of flower development | 20.14% (28/139) | 3.97 | 0.0 | 0.0 |
GO:0043412 | macromolecule modification | 36.69% (51/139) | 2.46 | 0.0 | 0.0 |
GO:0048831 | regulation of shoot system development | 20.14% (28/139) | 3.9 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 42.45% (59/139) | 2.17 | 0.0 | 0.0 |
GO:0006261 | DNA-dependent DNA replication | 16.55% (23/139) | 4.48 | 0.0 | 0.0 |
GO:0048451 | petal formation | 12.23% (17/139) | 5.55 | 0.0 | 0.0 |
GO:0048453 | sepal formation | 12.23% (17/139) | 5.55 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 47.48% (66/139) | 1.93 | 0.0 | 0.0 |
GO:2000241 | regulation of reproductive process | 20.14% (28/139) | 3.7 | 0.0 | 0.0 |
GO:0044267 | cellular protein metabolic process | 35.25% (49/139) | 2.36 | 0.0 | 0.0 |
GO:0048580 | regulation of post-embryonic development | 20.14% (28/139) | 3.55 | 0.0 | 0.0 |
GO:2000026 | regulation of multicellular organismal development | 20.14% (28/139) | 3.53 | 0.0 | 0.0 |
GO:0016572 | histone phosphorylation | 10.79% (15/139) | 5.59 | 0.0 | 0.0 |
GO:0051239 | regulation of multicellular organismal process | 20.14% (28/139) | 3.42 | 0.0 | 0.0 |
GO:0031048 | heterochromatin assembly by small RNA | 12.23% (17/139) | 4.88 | 0.0 | 0.0 |
GO:0006346 | DNA methylation-dependent heterochromatin assembly | 12.23% (17/139) | 4.75 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 32.37% (45/139) | 2.28 | 0.0 | 0.0 |
GO:0031047 | gene silencing by RNA | 12.95% (18/139) | 4.48 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 27.34% (38/139) | 2.56 | 0.0 | 0.0 |
GO:0050793 | regulation of developmental process | 23.02% (32/139) | 2.87 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 36.69% (51/139) | 1.96 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 28.06% (39/139) | 2.41 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 48.2% (67/139) | 1.55 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 16.55% (23/139) | 3.54 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 9.35% (13/139) | 5.29 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 34.53% (48/139) | 1.99 | 0.0 | 0.0 |
GO:0031507 | heterochromatin assembly | 12.23% (17/139) | 4.29 | 0.0 | 0.0 |
GO:0070828 | heterochromatin organization | 12.23% (17/139) | 4.28 | 0.0 | 0.0 |
GO:0045814 | negative regulation of gene expression, epigenetic | 12.23% (17/139) | 4.26 | 0.0 | 0.0 |
GO:0006325 | chromatin organization | 13.67% (19/139) | 3.86 | 0.0 | 0.0 |
GO:0040029 | regulation of gene expression, epigenetic | 12.23% (17/139) | 4.07 | 0.0 | 0.0 |
GO:0003774 | cytoskeletal motor activity | 9.35% (13/139) | 4.94 | 0.0 | 0.0 |
GO:0051225 | spindle assembly | 7.91% (11/139) | 5.57 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 33.09% (46/139) | 1.93 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 25.18% (35/139) | 2.37 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 17.99% (25/139) | 3.02 | 0.0 | 0.0 |
GO:0007051 | spindle organization | 7.91% (11/139) | 5.51 | 0.0 | 0.0 |
GO:0140694 | non-membrane-bounded organelle assembly | 7.91% (11/139) | 5.51 | 0.0 | 0.0 |
GO:0070925 | organelle assembly | 7.91% (11/139) | 5.48 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 17.99% (25/139) | 2.95 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 34.53% (48/139) | 1.77 | 0.0 | 0.0 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 28.78% (40/139) | 2.04 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 28.78% (40/139) | 2.04 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 28.78% (40/139) | 2.0 | 0.0 | 0.0 |
GO:0005634 | nucleus | 64.75% (90/139) | 0.95 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 33.09% (46/139) | 1.75 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 34.53% (48/139) | 1.69 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 28.78% (40/139) | 1.92 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 34.53% (48/139) | 1.62 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 29.5% (41/139) | 1.82 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 20.86% (29/139) | 2.3 | 0.0 | 0.0 |
GO:0009987 | cellular process | 66.19% (92/139) | 0.86 | 0.0 | 0.0 |
GO:0140657 | ATP-dependent activity | 12.95% (18/139) | 3.22 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 34.53% (48/139) | 1.55 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 41.01% (57/139) | 1.29 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 5.76% (8/139) | 5.43 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 43.17% (60/139) | 1.23 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 36.69% (51/139) | 1.36 | 0.0 | 0.0 |
GO:0006468 | protein phosphorylation | 12.95% (18/139) | 2.9 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 36.69% (51/139) | 1.36 | 0.0 | 0.0 |
GO:0032502 | developmental process | 33.81% (47/139) | 1.43 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 25.18% (35/139) | 1.72 | 0.0 | 0.0 |
GO:0042127 | regulation of cell population proliferation | 7.19% (10/139) | 4.08 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 41.01% (57/139) | 1.14 | 0.0 | 0.0 |
GO:0000724 | double-strand break repair via homologous recombination | 5.76% (8/139) | 4.59 | 0.0 | 0.0 |
GO:0000725 | recombinational repair | 5.76% (8/139) | 4.59 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 48.92% (68/139) | 0.95 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 28.78% (40/139) | 1.45 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 28.78% (40/139) | 1.44 | 0.0 | 0.0 |
GO:0006302 | double-strand break repair | 6.47% (9/139) | 4.11 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 49.64% (69/139) | 0.91 | 0.0 | 0.0 |
GO:0044786 | cell cycle DNA replication | 6.47% (9/139) | 4.0 | 0.0 | 0.0 |
GO:1902407 | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0000914 | phragmoplast assembly | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0032506 | cytokinetic process | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:1902410 | mitotic cytokinetic process | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0016310 | phosphorylation | 12.95% (18/139) | 2.38 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 44.6% (62/139) | 0.96 | 0.0 | 0.0 |
GO:0001708 | cell fate specification | 5.04% (7/139) | 4.64 | 0.0 | 0.0 |
GO:0051276 | chromosome organization | 7.91% (11/139) | 3.27 | 0.0 | 0.0 |
GO:0000280 | nuclear division | 5.04% (7/139) | 4.47 | 0.0 | 0.0 |
GO:0006310 | DNA recombination | 7.91% (11/139) | 3.21 | 0.0 | 0.0 |
GO:0003006 | developmental process involved in reproduction | 20.86% (29/139) | 1.63 | 0.0 | 0.0 |
GO:0010948 | negative regulation of cell cycle process | 3.6% (5/139) | 5.64 | 0.0 | 0.0 |
GO:0022414 | reproductive process | 23.02% (32/139) | 1.51 | 0.0 | 0.0 |
GO:0006281 | DNA repair | 7.91% (11/139) | 3.14 | 0.0 | 0.0 |
GO:0005488 | binding | 41.01% (57/139) | 0.96 | 0.0 | 1e-06 |
GO:0042023 | DNA endoreduplication | 5.76% (8/139) | 3.84 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 49.64% (69/139) | 0.8 | 0.0 | 1e-06 |
GO:0022607 | cellular component assembly | 12.23% (17/139) | 2.24 | 0.0 | 1e-06 |
GO:0000278 | mitotic cell cycle | 6.47% (9/139) | 3.47 | 0.0 | 1e-06 |
GO:1901988 | negative regulation of cell cycle phase transition | 2.88% (4/139) | 6.18 | 0.0 | 1e-06 |
GO:0000075 | cell cycle checkpoint signaling | 2.88% (4/139) | 6.18 | 0.0 | 1e-06 |
GO:0071103 | DNA conformation change | 3.6% (5/139) | 5.2 | 0.0 | 1e-06 |
GO:0044815 | DNA packaging complex | 2.88% (4/139) | 6.05 | 0.0 | 2e-06 |
GO:0006974 | cellular response to DNA damage stimulus | 7.91% (11/139) | 2.89 | 0.0 | 2e-06 |
GO:0048285 | organelle fission | 5.04% (7/139) | 3.87 | 1e-06 | 3e-06 |
GO:0009957 | epidermal cell fate specification | 2.88% (4/139) | 5.73 | 1e-06 | 5e-06 |
GO:0010583 | response to cyclopentenone | 5.76% (8/139) | 3.43 | 1e-06 | 5e-06 |
GO:0010468 | regulation of gene expression | 20.86% (29/139) | 1.4 | 1e-06 | 7e-06 |
GO:0140097 | catalytic activity, acting on DNA | 5.04% (7/139) | 3.68 | 1e-06 | 8e-06 |
GO:0007049 | cell cycle | 6.47% (9/139) | 3.03 | 2e-06 | 1e-05 |
GO:0099080 | supramolecular complex | 4.32% (6/139) | 4.03 | 2e-06 | 1e-05 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.6% (5/139) | 4.6 | 2e-06 | 1.1e-05 |
GO:0043228 | non-membrane-bounded organelle | 10.79% (15/139) | 2.11 | 2e-06 | 1.2e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.79% (15/139) | 2.11 | 2e-06 | 1.2e-05 |
GO:0044249 | cellular biosynthetic process | 27.34% (38/139) | 1.11 | 3e-06 | 1.4e-05 |
GO:0045786 | negative regulation of cell cycle | 3.6% (5/139) | 4.4 | 4e-06 | 2.1e-05 |
GO:0051784 | negative regulation of nuclear division | 2.16% (3/139) | 6.41 | 4e-06 | 2.3e-05 |
GO:0007349 | cellularization | 2.16% (3/139) | 6.41 | 4e-06 | 2.3e-05 |
GO:0009524 | phragmoplast | 3.6% (5/139) | 4.34 | 5e-06 | 2.5e-05 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 2.16% (3/139) | 6.22 | 7e-06 | 3.6e-05 |
GO:1901576 | organic substance biosynthetic process | 28.06% (39/139) | 0.99 | 1.3e-05 | 6.9e-05 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.16% (3/139) | 5.9 | 1.5e-05 | 7.5e-05 |
GO:0005730 | nucleolus | 6.47% (9/139) | 2.64 | 1.6e-05 | 8.2e-05 |
GO:0000796 | condensin complex | 1.44% (2/139) | 7.64 | 2.5e-05 | 0.000127 |
GO:0006796 | phosphate-containing compound metabolic process | 15.83% (22/139) | 1.4 | 2.7e-05 | 0.000133 |
GO:0000228 | nuclear chromosome | 2.16% (3/139) | 5.64 | 2.6e-05 | 0.000133 |
GO:0009058 | biosynthetic process | 28.06% (39/139) | 0.95 | 2.7e-05 | 0.000135 |
GO:0006793 | phosphorus metabolic process | 15.83% (22/139) | 1.39 | 3.2e-05 | 0.00016 |
GO:0032993 | protein-DNA complex | 2.16% (3/139) | 5.31 | 5.4e-05 | 0.000264 |
GO:0051783 | regulation of nuclear division | 2.16% (3/139) | 5.31 | 5.4e-05 | 0.000264 |
GO:0005694 | chromosome | 2.88% (4/139) | 4.21 | 6.5e-05 | 0.000314 |
GO:0000776 | kinetochore | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000358 |
GO:0030261 | chromosome condensation | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000358 |
GO:0006323 | DNA packaging | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000358 |
GO:0005874 | microtubule | 2.88% (4/139) | 4.08 | 9.2e-05 | 0.000437 |
GO:0010639 | negative regulation of organelle organization | 2.16% (3/139) | 4.97 | 0.000114 | 0.000532 |
GO:0051129 | negative regulation of cellular component organization | 2.16% (3/139) | 4.97 | 0.000114 | 0.000532 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0033045 | regulation of sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0031577 | spindle checkpoint signaling | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:1905819 | negative regulation of chromosome separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0031570 | DNA integrity checkpoint signaling | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:1905818 | regulation of chromosome separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0032137 | guanine/thymine mispair binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0000400 | four-way junction DNA binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0032138 | single base insertion or deletion binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0051985 | negative regulation of chromosome segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0071173 | spindle assembly checkpoint signaling | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0071174 | mitotic spindle checkpoint signaling | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0032301 | MutSalpha complex | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0051983 | regulation of chromosome segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.44% (2/139) | 6.64 | 0.00015 | 0.000618 |
GO:0051258 | protein polymerization | 2.16% (3/139) | 4.83 | 0.000155 | 0.000636 |
GO:0048229 | gametophyte development | 5.04% (7/139) | 2.58 | 0.000183 | 0.000749 |
GO:0099513 | polymeric cytoskeletal fiber | 2.88% (4/139) | 3.8 | 0.000196 | 0.000791 |
GO:0099512 | supramolecular fiber | 2.88% (4/139) | 3.8 | 0.000196 | 0.000791 |
GO:0099081 | supramolecular polymer | 2.88% (4/139) | 3.8 | 0.000196 | 0.000791 |
GO:0007000 | nucleolus organization | 2.16% (3/139) | 4.64 | 0.000233 | 0.000933 |
GO:1903046 | meiotic cell cycle process | 5.04% (7/139) | 2.52 | 0.000237 | 0.000944 |
GO:0042575 | DNA polymerase complex | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:0009558 | embryo sac cellularization | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:0032135 | DNA insertion or deletion binding | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:2001251 | negative regulation of chromosome organization | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:0043570 | maintenance of DNA repeat elements | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.44% (2/139) | 6.31 | 0.000248 | 0.000962 |
GO:0043231 | intracellular membrane-bounded organelle | 74.1% (103/139) | 0.3 | 0.00036 | 0.001389 |
GO:0043227 | membrane-bounded organelle | 74.1% (103/139) | 0.3 | 0.000367 | 0.001409 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.44% (2/139) | 6.05 | 0.000371 | 0.001412 |
GO:0007088 | regulation of mitotic nuclear division | 1.44% (2/139) | 6.05 | 0.000371 | 0.001412 |
GO:0016246 | RNA interference | 2.88% (4/139) | 3.55 | 0.000388 | 0.001468 |
GO:0000018 | regulation of DNA recombination | 1.44% (2/139) | 5.83 | 0.000518 | 0.001942 |
GO:0045910 | negative regulation of DNA recombination | 1.44% (2/139) | 5.83 | 0.000518 | 0.001942 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 2.16% (3/139) | 4.22 | 0.000554 | 0.002067 |
GO:0051052 | regulation of DNA metabolic process | 2.88% (4/139) | 3.41 | 0.000563 | 0.002093 |
GO:0014070 | response to organic cyclic compound | 5.76% (8/139) | 2.1 | 0.000607 | 0.002244 |
GO:0043229 | intracellular organelle | 74.1% (103/139) | 0.29 | 0.000632 | 0.002326 |
GO:0043226 | organelle | 74.1% (103/139) | 0.29 | 0.000643 | 0.002357 |
GO:0035194 | post-transcriptional gene silencing by RNA | 2.88% (4/139) | 3.35 | 0.000654 | 0.002383 |
GO:0000217 | DNA secondary structure binding | 1.44% (2/139) | 5.64 | 0.000689 | 0.002466 |
GO:0051053 | negative regulation of DNA metabolic process | 1.44% (2/139) | 5.64 | 0.000689 | 0.002466 |
GO:0000710 | meiotic mismatch repair | 1.44% (2/139) | 5.64 | 0.000689 | 0.002466 |
GO:0005875 | microtubule associated complex | 1.44% (2/139) | 5.64 | 0.000689 | 0.002466 |
GO:0019887 | protein kinase regulator activity | 2.16% (3/139) | 4.01 | 0.000852 | 0.003038 |
GO:0006268 | DNA unwinding involved in DNA replication | 1.44% (2/139) | 5.47 | 0.000882 | 0.003133 |
GO:0019207 | kinase regulator activity | 2.16% (3/139) | 3.9 | 0.001071 | 0.003787 |
GO:0032300 | mismatch repair complex | 1.44% (2/139) | 5.31 | 0.001099 | 0.003835 |
GO:0030983 | mismatched DNA binding | 1.44% (2/139) | 5.31 | 0.001099 | 0.003835 |
GO:0000786 | nucleosome | 1.44% (2/139) | 5.31 | 0.001099 | 0.003835 |
GO:0000793 | condensed chromosome | 1.44% (2/139) | 5.18 | 0.001339 | 0.004632 |
GO:1990391 | DNA repair complex | 1.44% (2/139) | 5.18 | 0.001339 | 0.004632 |
GO:0033043 | regulation of organelle organization | 3.6% (5/139) | 2.55 | 0.001715 | 0.005907 |
GO:0061982 | meiosis I cell cycle process | 2.88% (4/139) | 2.96 | 0.001774 | 0.006086 |
GO:0005524 | ATP binding | 5.76% (8/139) | 1.85 | 0.001797 | 0.006136 |
GO:0032508 | DNA duplex unwinding | 1.44% (2/139) | 4.94 | 0.001887 | 0.006416 |
GO:0097435 | supramolecular fiber organization | 3.6% (5/139) | 2.49 | 0.002045 | 0.006898 |
GO:0003674 | molecular_function | 83.45% (116/139) | 0.2 | 0.002038 | 0.006901 |
GO:0030554 | adenyl nucleotide binding | 5.76% (8/139) | 1.81 | 0.002122 | 0.007098 |
GO:0032559 | adenyl ribonucleotide binding | 5.76% (8/139) | 1.81 | 0.002122 | 0.007098 |
GO:0032392 | DNA geometric change | 1.44% (2/139) | 4.83 | 0.002194 | 0.007307 |
GO:0006298 | mismatch repair | 1.44% (2/139) | 4.73 | 0.002523 | 0.008334 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.44% (2/139) | 4.73 | 0.002523 | 0.008334 |
GO:0140513 | nuclear protein-containing complex | 3.6% (5/139) | 2.4 | 0.002656 | 0.008701 |
GO:0009965 | leaf morphogenesis | 3.6% (5/139) | 2.4 | 0.002656 | 0.008701 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 5.04% (7/139) | 1.89 | 0.002994 | 0.009768 |
GO:0035639 | purine ribonucleoside triphosphate binding | 6.47% (9/139) | 1.58 | 0.003289 | 0.01069 |
GO:0032991 | protein-containing complex | 10.79% (15/139) | 1.14 | 0.003456 | 0.011188 |
GO:0032555 | purine ribonucleotide binding | 6.47% (9/139) | 1.56 | 0.003746 | 0.012078 |
GO:0017076 | purine nucleotide binding | 6.47% (9/139) | 1.55 | 0.003786 | 0.012159 |
GO:0032553 | ribonucleotide binding | 6.47% (9/139) | 1.54 | 0.003993 | 0.01277 |
GO:0009971 | anastral spindle assembly involved in male meiosis | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0016895 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0055048 | anastral spindle assembly | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0005657 | replication fork | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0005658 | alpha DNA polymerase:primase complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0035402 | histone kinase activity (H3-T11 specific) | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0045005 | DNA-dependent DNA replication maintenance of fidelity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0035822 | gene conversion | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0045004 | DNA replication proofreading | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0043625 | delta DNA polymerase complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0043137 | DNA replication, removal of RNA primer | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0006269 | DNA replication, synthesis of RNA primer | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0016048 | detection of temperature stimulus | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0032302 | MutSbeta complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0072354 | histone kinase activity (H3-T3 specific) | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0033260 | nuclear DNA replication | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0004170 | dUTP diphosphatase activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0007076 | mitotic chromosome condensation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0035407 | histone H3-T11 phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0000403 | Y-form DNA binding | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0035184 | histone threonine kinase activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0000406 | double-strand/single-strand DNA junction binding | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0018210 | peptidyl-threonine modification | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0006311 | meiotic gene conversion | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0006279 | premeiotic DNA replication | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0008296 | 3'-5'-exodeoxyribonuclease activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0006287 | base-excision repair, gap-filling | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0004529 | exodeoxyribonuclease activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0072355 | histone H3-T3 phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0005872 | minus-end kinesin complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0008569 | minus-end-directed microtubule motor activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0035405 | histone-threonine phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0007053 | spindle assembly involved in male meiosis | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0018107 | peptidyl-threonine phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013826 |
GO:0097367 | carbohydrate derivative binding | 6.47% (9/139) | 1.52 | 0.004431 | 0.014118 |
GO:0003684 | damaged DNA binding | 1.44% (2/139) | 4.31 | 0.004491 | 0.014251 |
GO:0035825 | homologous recombination | 2.88% (4/139) | 2.53 | 0.005258 | 0.014414 |
GO:0009553 | embryo sac development | 2.16% (3/139) | 3.16 | 0.004707 | 0.014877 |
GO:0010103 | stomatal complex morphogenesis | 2.88% (4/139) | 2.51 | 0.00553 | 0.015058 |
GO:0090626 | plant epidermis morphogenesis | 2.88% (4/139) | 2.51 | 0.00553 | 0.015058 |
GO:0003713 | transcription coactivator activity | 1.44% (2/139) | 4.24 | 0.004947 | 0.015516 |
GO:0034061 | DNA polymerase activity | 1.44% (2/139) | 4.24 | 0.004947 | 0.015516 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.6% (5/139) | 2.13 | 0.005893 | 0.015992 |
GO:0043168 | anion binding | 6.47% (9/139) | 1.42 | 0.006701 | 0.018123 |
GO:0090329 | regulation of DNA-dependent DNA replication | 1.44% (2/139) | 3.99 | 0.006976 | 0.018804 |
GO:0110165 | cellular anatomical entity | 92.09% (128/139) | 0.12 | 0.007314 | 0.01965 |
GO:0005515 | protein binding | 13.67% (19/139) | 0.88 | 0.00744 | 0.019922 |
GO:0016441 | posttranscriptional gene silencing | 2.88% (4/139) | 2.37 | 0.007704 | 0.020494 |
GO:0007129 | homologous chromosome pairing at meiosis | 2.16% (3/139) | 2.9 | 0.0077 | 0.020549 |
GO:0033554 | cellular response to stress | 8.63% (12/139) | 1.15 | 0.008194 | 0.021725 |
GO:0004674 | protein serine/threonine kinase activity | 4.32% (6/139) | 1.78 | 0.008445 | 0.022316 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 2.16% (3/139) | 2.85 | 0.008517 | 0.022435 |
GO:0045787 | positive regulation of cell cycle | 1.44% (2/139) | 3.83 | 0.008703 | 0.022849 |
GO:0006084 | acetyl-CoA metabolic process | 2.16% (3/139) | 2.81 | 0.00909 | 0.023787 |
GO:0006997 | nucleus organization | 2.16% (3/139) | 2.8 | 0.009384 | 0.024478 |
GO:0030337 | DNA polymerase processivity factor activity | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0090306 | meiotic spindle assembly | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0010520 | regulation of reciprocal meiotic recombination | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0000404 | heteroduplex DNA loop binding | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0005971 | ribonucleoside-diphosphate reductase complex | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0045835 | negative regulation of meiotic nuclear division | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0010342 | endosperm cellularization | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0005871 | kinesin complex | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0008574 | plus-end-directed microtubule motor activity | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0000819 | sister chromatid segregation | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0051447 | negative regulation of meiotic cell cycle | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0047429 | nucleoside-triphosphate diphosphatase activity | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0006271 | DNA strand elongation involved in DNA replication | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0048314 | embryo sac morphogenesis | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0000076 | DNA replication checkpoint signaling | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0022616 | DNA strand elongation | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0005640 | nuclear outer membrane | 0.72% (1/139) | 6.64 | 0.010027 | 0.02464 |
GO:0035383 | thioester metabolic process | 2.16% (3/139) | 2.75 | 0.010301 | 0.025159 |
GO:0006637 | acyl-CoA metabolic process | 2.16% (3/139) | 2.75 | 0.010301 | 0.025159 |
GO:0000166 | nucleotide binding | 7.19% (10/139) | 1.24 | 0.010396 | 0.025238 |
GO:1901265 | nucleoside phosphate binding | 7.19% (10/139) | 1.24 | 0.010396 | 0.025238 |
GO:0003712 | transcription coregulator activity | 1.44% (2/139) | 3.73 | 0.00995 | 0.025871 |
GO:0016444 | somatic cell DNA recombination | 1.44% (2/139) | 3.64 | 0.011272 | 0.0272 |
GO:0006338 | chromatin remodeling | 1.44% (2/139) | 3.64 | 0.011272 | 0.0272 |
GO:0005575 | cellular_component | 94.96% (132/139) | 0.09 | 0.011336 | 0.027275 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028473 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028473 |
GO:0033865 | nucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028473 |
GO:0051128 | regulation of cellular component organization | 3.6% (5/139) | 1.87 | 0.012457 | 0.029617 |
GO:0045010 | actin nucleation | 2.16% (3/139) | 2.56 | 0.014474 | 0.034312 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0000212 | meiotic spindle organization | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0080175 | phragmoplast microtubule organization | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0010434 | bract formation | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.72% (1/139) | 6.05 | 0.015003 | 0.034452 |
GO:0030234 | enzyme regulator activity | 2.88% (4/139) | 2.0 | 0.018256 | 0.041801 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 2.16% (3/139) | 2.43 | 0.018582 | 0.042309 |
GO:0048523 | negative regulation of cellular process | 5.04% (7/139) | 1.38 | 0.018578 | 0.04242 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 1.44% (2/139) | 3.24 | 0.018938 | 0.042997 |
GO:0051716 | cellular response to stimulus | 8.63% (12/139) | 0.98 | 0.019589 | 0.04435 |
GO:1905392 | plant organ morphogenesis | 3.6% (5/139) | 1.7 | 0.019681 | 0.044434 |
GO:0035173 | histone kinase activity | 0.72% (1/139) | 5.64 | 0.019955 | 0.044553 |
GO:0031261 | DNA replication preinitiation complex | 0.72% (1/139) | 5.64 | 0.019955 | 0.044553 |
GO:0000731 | DNA synthesis involved in DNA repair | 0.72% (1/139) | 5.64 | 0.019955 | 0.044553 |
GO:0008017 | microtubule binding | 1.44% (2/139) | 3.21 | 0.019797 | 0.044571 |
GO:0098772 | molecular function regulator | 2.88% (4/139) | 1.94 | 0.021085 | 0.046946 |